The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1545-1549

  Praditpornsilpa, Kearkiat ^a,i   Kupatawintu, Pawinee ^b   Mongkonsritagoon, Wichean ^c   Supasyndh, Ouppatham ^c   Jootar, Saengsuree ^d   Intarakumthornchai, Tanin ^a   Pongskul, Cholatip ^e   Prasithsirikul, Wisit ^f   Achavanuntakul, Bunlersak ^g   Ruangkarnchanasetr, Prajej ^c   Laohavinij, Sudsawat ^h   Eiam Ong, Somchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c PRAMONGKUTKLAO HOSPITAL   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e KHON KAEN UNIVERSITY   (Thailand)

^f Department of Medicine   (Thailand)

^g Sappasitthiprasong Hospital   (Thailand)

^h RAJAVITHI HOSPITAL   (Thailand)

ⁱ KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Anaemia; Anti r HuEpo associated pure red cell aplasia; Chronic kidney disease; Erythropoietin; HLA genotype

Indexed keywords

ERYTHROPOIETIN ANTIBODY; HLA A ANTIGEN; HLA A11 ANTIGEN; HLA A24 ANTIGEN; HLA B ANTIGEN; HLA B60 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; AGED; ALLELE; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HLA TYPING; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANEMIA; ANTIBODIES, ANTI-IDIOTYPIC; CASE-CONTROL STUDIES; CHRONIC DISEASE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INJECTIONS, SUBCUTANEOUS; KIDNEY DISEASES; MALE; MIDDLE AGED; RED-CELL APLASIA, PURE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 65249086211     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn450     Document Type: Article

References (17)

1. Pece R, de la Torre M, Alćazar R et al. Antibodies against recombinant erythropoietin in a patient with erythropoietin-resistant anemia. New Engl J Med 1990; 335: 523-524
2. PrabhakanS, MuhfelderT.Antibodies torecombinant humanerythro-poietin causing pure red cell aplasia. Clin Nephrol 1997; 47: 331-335
3. Bergrem H, Danielson BG, Eckardt KU et al. A case of antiery-thropoietin antibodies following recombinant human erythropoietin treatment. Erythropoietin: Molecular Physiology and Clinical Application. New York: Dekker, 1993, 266-275
4. Casadevall N, Nataf J, Viron B et al. Pure red-cell aplasia and antiery-thropoietin antibodies in patients treated with recombinant erythro-poietin. N Engl J Medw 2002; 347: 469-475
5. Bennett C, Luminari S, Nissenson AR et al. Pure red-cell aplasia and epoetin therapy. N Engl J Med 2004; 351: 35-40
6. Boven K, Stryker S, Knight J et al. The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney Int 2005; 67: 2346-2353
7. Praditpornsilpa K, Buranasot S, Bhokaisuwan N et al. Recovery of anti-recombinant-human-erythropoietin associated pure red cell apla-sia in end-stage renal disease patients after renal transplantation. Nephrol Dial Transplant 2005; 20: 626-630
8. Middleton D, Menchaca L, Rood H et al. www.allelefrequencies.net new allele frequency database. Tissue Antigens 2003; 61: 403-407
9. Mallal S, Nolan C, Witt C et al. Association between presence of HLA-B*5701, HLA-DR-7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002; 359: 727-732
10. Hung S, Chung W, Liou L et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134-4139
11. Casadevall N, Cournoyer D, Marsh J et al. Recommendations on the haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia. Eur J Haematol 2004; 73: 389-396
12. Roosert J, Casadevall N, Eckardt K. Anti-erythropoietin antibodies and pure red cell aplasia. J Am Soc Nephrol 2004; 5: 398-406
13. Tracey R, Greway A, Smiell J et al. The detection of anti-erythropoietin antibodies in human serum and plasma: Part I. Validation of the protocol for a radioimmunoprecipitation assay. J Immunol Methods 2003; 283: 317-329
14. Kelley M, Cooper C, Matticoli A et al. The detection of anti-erythropoietin antibodies in human serum and plasma: Part II. Validation of a semi-quantitative 3H-thymidine uptake assay for neutralizing antibodies. J Immunol Methods 2005; 300: 179-191
15. Porter S. Human immune response to recombinant human proteins. J Pharm Sci 2001; 90: 1-11
16. Fijal B, Ricci D, Vercammer E et al. Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia. Pharmacogenomics 2008; 9: 157-167
17. Kawabata Y, Ikegami H, Kawaguchi Y et al. Asian-Specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 2002; 51: 545-551